- Physician Assistants
- Nurse Practitioners
Participants who engage in this educational intervention will be able to:
- Gain knowledge about potential role of p66Shc adaptor protein in loss of microvascular reactivity.
- Gain understanding of how p66Shc-mediated vascular function could be restored.
- Evaluate available small compound inhibitors as candidates for treatment of p66Shc-mediated hypertension-induced nephrology.
Andrey Sorokin, PhD
Professor of Medicine
Division of Nephrology
Medical College of Wisconsin
In accordance with the ACCME® Standards for Commercial Support Six, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.
- Andrey Sorokin, PhD
In accordance with the ACCME® Standards for Commercial Support Six, all in control of content must disclose any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved.
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians
Designation of Credit Statement
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
Hours of Participation for Allied Health Professionals
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.